Apyx Medical Balance Sheet Health
Financial Health criteria checks 5/6
Apyx Medical has a total shareholder equity of $14.9M and total debt of $33.6M, which brings its debt-to-equity ratio to 225.3%. Its total assets and total liabilities are $65.4M and $50.5M respectively.
Key information
225.3%
Debt to equity ratio
US$33.63m
Debt
| Interest coverage ratio | n/a |
| Cash | US$32.68m |
| Equity | US$14.92m |
| Total liabilities | US$50.47m |
| Total assets | US$65.39m |
Recent financial health updates
Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?
Jun 19
Is Apyx Medical (NASDAQ:APYX) A Risky Investment?
Sep 14Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?
Jun 07Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation
Dec 14We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate
Aug 30Recent updates
Is There An Opportunity With Apyx Medical Corporation's (NASDAQ:APYX) 41% Undervaluation?
Sep 14Apyx Medical Corporation (NASDAQ:APYX) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Aug 07We Discuss Why Apyx Medical Corporation's (NASDAQ:APYX) CEO Compensation May Be Closely Reviewed
Aug 01Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?
Jun 19Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive
Apr 18Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates
Mar 26Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)
Feb 16Is Apyx Medical (NASDAQ:APYX) A Risky Investment?
Sep 14Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?
Jun 07Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically
Mar 21Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation
Dec 14We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate
Aug 30Apyx Medical GAAP EPS of -$0.16 beats by $0.03, revenue of $10.3M misses by $0.26M
Aug 11Apyx Medical gets FDA nod for Renuvion's use in improving loose skin on neck, chin
Jul 18Financial Position Analysis
Short Term Liabilities: APYX's short term assets ($56.7M) exceed its short term liabilities ($10.6M).
Long Term Liabilities: APYX's short term assets ($56.7M) exceed its long term liabilities ($39.8M).
Debt to Equity History and Analysis
Debt Level: APYX's net debt to equity ratio (6.4%) is considered satisfactory.
Reducing Debt: APYX's debt to equity ratio has increased from 0.2% to 225.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: APYX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: APYX has sufficient cash runway for 2.8 years if free cash flow continues to grow at historical rates of 8.1% each year.